Fontan Procedure (Total Cavopulmonary Connection (TCPC))

Date
October 12, 2025
URL
https://x.com/WithAScalpel/status/1977345938495504703
Categories
FontanCardiac SurgerySingle Ventricle

Fontan Completion — Operative Principles, Steps, and Pitfalls

image

Purpose and physiologic intent

Fontan completion connects inferior vena caval (IVC) return to the pulmonary arteries (PAs) to establish a total cavopulmonary connection (TCPC) in patients with a prior bidirectional Glenn. The systemic venous circulation is routed in parallel to the lungs, while the single ventricle performs systemic work. Contemporary consensus emphasizes that durable success requires unobstructed venous pathways, low pulmonary vascular resistance (PVR), and sufficient preload to drive non-pulsatile pulmonary flow—tenets reiterated in the AHA Scientific Statement and long-term outcome reviews [1, 2]. Extracardiac TCPC is now the most frequently used configuration worldwide, reflecting favorable hemodynamics and simplicity of re-entry [2]. Ten-year survival after modern extracardiac TCPC commonly approaches ~92–96%, although late morbid events remain prevalent and drive attrition of event-free survival [3–5].

Operative setup

  • Cannulation & CPB. Arterial cannulation in the aorta; venous drainage via the SVC and a low IVC (or femoral/right atrium as exposure dictates) to maintain a dry field and minimize air entrainment.
  • Hemodynamic goals on bypass. Maintain low PVR (high FiO₂, normothermia with mild alkalosis, gentle ventilation or “lungs down” during key steps) and adequate venous return to prevent conduit collapse once flow is established. These strategies are aligned with guideline-based perioperative principles for Fontan physiology [1].

Stepwise technique (extracardiac conduit approach)

  1. PA & SVC control. Snare the branch PAs and SVC for a motionless, bloodless field and to prevent venous runoff during anastomoses; confirm caliber and patency of both branch PAs.
  2. Proximal (PA) anastomosis. Open the right PA longitudinally at a site that aligns with the planned conduit trajectory; sew an 18–20 mm conduit end-to-side to the PA.
    • Pearls: Bevel to align inflow; avoid purse-string narrowing; keep heel/toe flush to minimize jets and turbulence.
  3. RA–IVC isolation. Snare the IVC and clamp the RA. Divide the RA–IVC junction and close the atrial cuff. Verify that coronary sinus drainage is uncompromised (surface EKG/atrial electrograms), as injury or distortion may provoke ischemia-like changes or atrial arrhythmias.
  4. Distal (IVC) anastomosis. Bevel the caudal conduit and perform an end-to-end anastomosis to the IVC (or to a prepared IVC cuff), ensuring a short, straight, non-kinked course from abdomen to PA.
    • Pearls: Avoid compression at the diaphragmatic hiatus; route anterior to the right pulmonary veins and posterior to the sternum to reduce kinking and facilitate future re-entry.
  5. De-airing and reperfusion. Sequentially release clamps to re-establish Glenn and IVC flows; confirm uniform color change and laminar venous return with a gentle gradient.
  6. Weaning from CPB. Actively optimize low PVR (full lung recruitment, high FiO₂, normocapnia→mild hypocapnia, warm patient) and adequate preload; avoid excessive PEEP that impedes venous return [1].
Optional fenestration. In high-risk physiology (borderline PVR, small PAs, marginal ventricular compliance, or elevated CVP during test clamp), a controlled right-to-left fenestration can improve early hemodynamics and reduce prolonged pleural drainage, accepting lower early SaO₂; meta-analysis and contemporary series show reduced PA pressures/pleural effusions without a survival advantage [1, 7].

Intraoperative assessment and targets

  • Pathway checks: No twist, kink, or hourglass narrowing; wide PA anastomosis without ridges or rotational mismatch; branch PAs free of distortion.
  • TEE/epicardial echo: Unobstructed conduit, competent AV valve, preserved systolic/diastolic function, and no occult shunts or PA stenoses.
  • Typical pressure targets: Fontan pressure in the mid-teens (~12–18 mmHg) with an acceptable transpulmonary gradient, stable systemic arterial pressure, adequate mixed venous saturation, and low lactate. These physiologic goals mirror guideline recommendations and high-volume center practice patterns [1, 4].

Postoperative management priorities

  • Ventilation: Early recruitment and prompt transition toward spontaneous breathing; avoid high PEEP that impedes cavopulmonary flow [1].
  • PVR modulation: High FiO₂ initially, normothermia, analgesia, avoidance of acidosis; consider inhaled pulmonary vasodilators (e.g., inhaled NO) selectively [1].
  • Preload/afterload: Maintain intravascular volume; delay aggressive diuresis if Fontan pressures are marginal, then introduce diuretics to mitigate effusions once stable [1, 8].
  • Rhythm: Preserve sinus rhythm/AV synchrony; treat junctional tachycardia or atrial arrhythmias promptly given their disproportionate impact on passive pulmonary flow [1, 9].
  • Thromboprophylaxis: Antiplatelet therapy is routine; consider anticoagulation for smaller conduits, sluggish flow, atrial dilation, prior thrombosis, or other risk markers—tailored per institutional protocols and consensus guidance [1, 8].
  • Surveillance: Serial imaging (echo, cross-sectional as indicated) to exclude effusions, pathway obstruction, or PA distortion; routine evaluation for Fontan-associated liver disease and lymphatic complications within structured follow-up programs [1].

Pitfalls and how to avoid them

  • Conduit kinking/compression: Prevent with a short, straight route and correct beveling; confirm with direct inspection and intraoperative echo.
  • PA distortion/anastomotic stenosis: Use a generous arteriotomy and avoid rotational malalignment; patch-augment if branch caliber is borderline.
  • Sinus node/coronary sinus injury: Respect the RA–IVC region; explicitly confirm coronary sinus patency before closure.
  • High early Fontan pressures: Revisit ventilation (reduce PEEP, correct hypercarbia/acidosis), check the pathway for obstruction, and consider fenestration if physiology remains marginal [1, 7].
  • Persistent effusions/low output: Consider lymphatic hypertension, occult PA stenosis, or diastolic dysfunction; escalate with targeted imaging and tailored therapy [1, 8, 9].

Long-term considerations

Even with technically optimal TCPC, the Fontan circulation carries lifelong risk of complications—arrhythmias, thromboembolism, lymphatic dysfunction (protein-losing enteropathy, plastic bronchitis), hepatic congestion/fibrosis, and eventual “Fontan failure.” Multicenter cohorts show excellent survival yet declining event-free survival (~64–77% at 10 years) due to late morbidities [4, 9]. Institution-level and population studies confirm good 10–15-year survival (≈90–96%) after extracardiac TCPC but underscore the cumulative burden of reintervention and organ sequelae, mandating structured surveillance and proactive risk reduction (lung health and exercise to keep PVR low, rhythm protection, thrombosis prevention, and dedicated liver/lymphatic follow-up) [3–6, 9, 10].

Practical checklist (condensed)

  • Plan a straight 18–20 mm extracardiac conduit with precise PA beveling.
  • Confirm a wide PA anastomosis and unimpeded IVC inflow; close the RA cuff without jeopardizing the coronary sinus.
  • Wean with low PVR + adequate preload; correct arrhythmias immediately.
  • Consider fenestration in physiologically borderline cases (pop-off for pressure, at the cost of SaO₂) [1, 7].
  • Begin antiplatelet ± anticoagulation, mobilize early, and commit to structured follow-up for lymphatic, hepatic, and rhythm surveillance [1, 8, 9].

Evidence snapshot (to complement your Elicit summary)

  • Technique of choice: Extracardiac TCPC is the predominant Fontan modification globally [2].
  • Survival: Large single-center and multicenter series report ~92–96% 10-year survival for extracardiac TCPC; examples include Nakano et al. (500 patients; 96% at 10 y, 93% at 15 y) and other cohorts with similar performance [3, 5]. Event-free survival declines over time due to rhythm, lymphatic, and hepatic complications [4, 6, 9].
  • Fenestration: Meta-analysis shows lower PA pressures and less prolonged pleural drainage, with trade-off of lower early SaO₂ and no clear survival advantage—supporting selective use in high-risk physiology [1, 7].
  • Post-Fontan programs: Consensus-driven protocols address anticoagulation, diuresis, ACE-inhibition where indicated, nutrition, fluid management, and a comprehensive surveillance toolkit for circulatory failure, arrhythmias, PLE, and Fontan-associated liver disease [1, 8].
  • Population impact: The number of people living with a Fontan circulation continues to grow, with increasing adult prevalence, reinforcing the need for life-course care models [10].

Key references supporting the above paragraphs: [1–10].

(Where ranges or figures are quoted, see the cited articles for cohort sizes and definitions.)

References

[1] Rychik J, Atz AM, Celermajer DS, Deal BJ, Gatzoulis MA, Gewillig M, et al.; American Heart Association Council on Cardiovascular Disease in the Young and Council on Cardiovascular and Stroke Nursing. Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association. Circulation. 2019;140(6):e234-e284. PubMed

[2] Kverneland LS, Kramer P, Ovroutski S. Five decades of the Fontan operation: A systematic review of international reports on outcomes after univentricular palliation. Congenit Heart Dis. 2018;13(2):181-193. PubMed

[3] Nakano T, Kado H, Tatewaki H, Hinokiyama K, Oda S, Ushinohama H, et al. Results of extracardiac conduit total cavopulmonary connection in 500 patients. Eur J Cardiothorac Surg. 2015;48(6):825-832; discussion 832. PubMed

[4] Tweddell JS, Nersesian M, Mussatto KA, Nugent M, Simpson P, Mitchell ME, et al. Fontan palliation in the modern era: factors impacting mortality and morbidity. Ann Thorac Surg. 2009;88(4):1291-1299. PubMed

[5] Kim SJ, Kim WH, Lim HG, Lee JY. Outcome of 200 patients after an extracardiac Fontan procedure. J Thorac Cardiovasc Surg. 2008;136(1):108-116.e1-5. PubMed

[6] Downing TE, Allen KY, Glatz AC, Rogers LS, Ravishankar C, Rychik J, et al. Long-term survival after the Fontan operation. J Thorac Cardiovasc Surg. 2017;154(1):243-253.e2. PubMed

[7] Bouhout I, Ben-Ali W, Khalaf D, Raboisson MJ, Poirier N. Effect of Fenestration on Fontan Procedure Outcomes: A Meta-Analysis and Review. Ann Thorac Surg. 2020;109(5):1467-1474. PubMed

[8] Al-Shawk M, Banjoko A, Axiaq A, Amin K, Harky A. Perioperative and long-term management of Fontan patients. Cardiol Young. 2021;31(5):775-785. PubMed

[9] Atz AM, Zak V, Mahony L, Uzark K, D’Agincourt N, Goldberg DJ, et al.; Pediatric Heart Network Investigators. Longitudinal Outcomes of Patients With Single Ventricle After the Fontan Procedure. J Am Coll Cardiol. 2017;69(22):2735-2744. PubMed

[10] Plappert L, Ewert P, Hager A, Rychik J, d’Udekem Y. The Epidemiology of Persons Living with Fontan in 2020 and Projections for 2030: A Multinational Study. Can J Cardiol. 2021;37(5):744-752. PMC